Very early researchStudy completedNCT03655704What this trial is testingApabetalone for Pulmonary Arterial Hypertension: a Pilot StudyWho this might be right forPulmonary Arterial Hypertension Steeve Provencher 7
Testing effectiveness (Phase 2)Looking for participantsNCT05577754What this trial is testingAssessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)Who this might be right forMegalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) Centre Hospitalier Universitaire Dijon 20
Testing effectiveness (Phase 2)UnknownNCT04915300What this trial is testingApabetalone for Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Laval University 72
Testing effectiveness (Phase 2)Looking for participantsNCT06789913What this trial is testingMutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA MutationWho this might be right forPIK3CA-Related Overgrowth Spectrum (PROS)Lymphatic MalformationsVascular Malformations+4 more Relay Therapeutics, Inc. 277
Not applicableLooking for participantsNCT05563831What this trial is testingNational Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)Who this might be right forPIK3CA-related Overgrowth SpectrumCLOVES SyndromeKlippel Trenaunay Syndrome+6 more Institut National de la Santé Et de la Recherche Médicale, France 2,500